StockData
Valneva SE logo

Valneva SE (VALN) stock

VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 17, 2026Score 1/30
$5.57−0.08 (-1.50%)

Close on Nov 17, 2026Market cap $482.87MP/E –Yield –

Valneva price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Valneva's price to sales ratio was 3.5× on Nov 11, 2026, against 3.1× a year earlier. Over the last 3 years it ranged from 1.5× to 23.5×, with a median of 3.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.5×+0.0
2025Oct 31, 20253.5×+0.3
2024Apr 30, 20243.1×+1.5
2023Apr 28, 20231.6×−0.4
2022Oct 31, 20222.0×−18.2
2021Dec 31, 202120.2×–

More Valneva figures

See a number that looks wrong?